Cordycepin synergizes with CTLA-4 blockade to remodel the tumor microenvironment for enhanced cancer immunotherapy

肿瘤微环境 癌症研究 封锁 虫草素 医学 CD8型 CTLA-4号机组 癌症 癌症免疫疗法 免疫疗法 FOXP3型 免疫系统 免疫学 T细胞 生物 内科学 受体 生物化学
作者
Lujun Chen,Xiao Wei Zheng,Hao Huang,Feng Chen,Shaoxian Wu,Rongzhang Chen,Hongwei� Jiang,Maoling Yuan,Yuanyuan Fu,Hanjie Ying,Jun Zhou,Jingting Jiang
出处
期刊:International Immunopharmacology [Elsevier BV]
卷期号:124 (Pt A): 110786-110786 被引量:20
标识
DOI:10.1016/j.intimp.2023.110786
摘要

The strategy of using immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment, leading to remarkable clinical outcomes. However, certain cancer types and patient demographics continue to face unique challenges. As a result, it is vital to investigate combination therapies that involve ICIs to boost therapeutic efficacy. Cordycepin, an adenosine derivative composed of adenine and pentose, holds immense promise for treating inflammation and cancer. Our recent research has demonstrated that the combined treatment of cordycepin and the anti-CD47 antibody significantly curtails tumor growth and extends the lifespan of tumor-bearing mice. In the current study, we showed that the combination of cordycepin and CTLA-4 blockade had a profound impact on suppressing tumor growth. We utilized the MC38 and CT26 tumor models to evaluate the therapeutic effect of cordycepin, CTLA-4 blockade, and their combined approach. Flow cytometry results unveiled that cordycepin, when combined with CTLA-4 blockade, considerably augmented the presence of tumor-infiltrating CD8+T cells and diminished the population of Foxp3+Tregs within the tumor microenvironment (TME). Additionally, we employed single-cell analysis to examine the TME's reconfiguration upon the combined treatment of anti-CTLA-4 and cordycepin. We observed a significant impact on inhibiting tumor growth and substantially extended survival in tumor-bearing mice. Our data also demonstrated an increased proportion of effector CD8+T cells in the combined treatment group compared to all other groups, while exhausted CD8+T cells diminished in the combined group compared to the anti-CTLA-4 treatment alone. In conclusion, our findings supported the idea that combining cordycepin and CTLA-4 blockade could modify the effector and exhaustion status of CD8+T cells, thereby bolstering CD8+T-cell-mediated anti-tumor immunity in the TME. Collectively, our current study successfully established a combination therapeutic strategy utilizing cordycepin and CTLA-4 blockade. This strategy demonstrated a significant synergistic effect against cancer, highlighting its importance in cancer treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
曾无忧完成签到,获得积分10
1秒前
勤劳凡雁完成签到,获得积分10
1秒前
Jyao完成签到,获得积分10
1秒前
害怕的小刺猬完成签到 ,获得积分10
1秒前
四叶草哦完成签到,获得积分10
1秒前
水煮电吹风的应助被情况有变采纳,获得10
2秒前
珍惜眼前人完成签到,获得积分10
2秒前
lvsoul完成签到,获得积分10
3秒前
JamesPei的应助被毗昙采纳,获得10
3秒前
落雪完成签到,获得积分10
3秒前
宁静致远QY完成签到,获得积分0
4秒前
SciGPT的应助被523采纳,获得10
4秒前
负责天问完成签到,获得积分10
4秒前
777完成签到 ,获得积分10
5秒前
5秒前
狂野的小熊猫完成签到,获得积分10
5秒前
Richard完成签到 ,获得积分10
5秒前
欢呼的白玉完成签到 ,获得积分10
5秒前
吴xx完成签到,获得积分10
6秒前
落后的嚣完成签到,获得积分10
6秒前
石守鹏完成签到,获得积分10
6秒前
不想看文献完成签到,获得积分10
6秒前
zhangr完成签到 ,获得积分10
6秒前
菲菲完成签到 ,获得积分10
6秒前
虚幻海之完成签到,获得积分10
7秒前
7秒前
suzhenyue完成签到,获得积分0
7秒前
乐语林晨完成签到,获得积分10
9秒前
9秒前
9秒前
忧郁的灵枫完成签到,获得积分10
9秒前
yz完成签到 ,获得积分10
9秒前
Jane完成签到 ,获得积分10
9秒前
温柔梦松完成签到 ,获得积分10
9秒前
ZH完成签到,获得积分10
10秒前
一凡卓完成签到 ,获得积分10
10秒前
南山完成签到,获得积分10
10秒前
CodeCraft的应助被dxzdxj采纳,获得10
10秒前
黄铁成完成签到,获得积分10
11秒前
张正友完成签到 ,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180146
求助须知:如何正确求助?哪些是违规求助? 9570319
关于积分的说明 21809739
捐赠科研通 7776294
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039